Nate Heintzman
About Nate Heintzman
Nate Heintzman is the founder of NanoCellect Biomedical, Inc. and has a strong background in biomedical sciences, specializing in cancer research and diabetes technology.
Work at NanoCellect Biomedical
Nate Heintzman has served as the Founder of NanoCellect Biomedical, Inc. since its inception in 2009. Over the past 15 years, he has played a pivotal role in the company's development and direction. His expertise in biomedical sciences and experience in the biotech industry have contributed to the company's focus on innovative solutions in cell sorting technology. Heintzman leverages his background in genomics and epigenetics to guide the company's projects and initiatives.
Education and Expertise
Heintzman earned a PhD in Biomedical Sciences from the UC San Diego School of Medicine, where he studied from 2001 to 2007. Prior to that, he obtained a BA in Biochemistry and Molecular Biology from Gustavus Adolphus College from 1997 to 2001. His academic background provides a strong foundation for his work in cancer systems research, particularly in genomics and epigenetics. Heintzman is known for applying critical thinking and project management skills to high-throughput applications in cancer research.
Background in Diabetes Technology
Nate Heintzman has a diverse background that includes significant roles in diabetes technology and informatics. He has worked at Dexcom in various capacities, including Director of Data Science, Director of Data Partnerships, and Senior Manager of Data Partnerships. His work at Dexcom has focused on data-driven solutions for diabetes management. Additionally, he has engaged in non-profit initiatives aimed at fitness and health management for individuals with diabetes.
Achievements in Research and Innovation
Heintzman founded the Diabetes Informatics & Analytics Lab (DIAL) at UC San Diego, which focuses on innovative approaches to diabetes care through informatics and analytics. He has also contributed to the diabetes community by developing programming initiatives that support individuals managing diabetes. His role as a judge for the Qualcomm Tricorder XPRIZE since 2014 highlights his commitment to advancing health technology and innovation.
Professional Experience at Dexcom
Nate Heintzman has held multiple positions at Dexcom, a leader in diabetes technology. He served as a Visiting Scientist from 2014 to 2015, and then as Director of Data Partnerships from 2017 to 2020. In his current role as Director of Data Science since 2020, he focuses on leveraging data to enhance diabetes management solutions. His extensive experience at Dexcom has solidified his expertise in data science and partnerships within the biotech industry.